Document is current
Any future updates will be listed below
-
Authors
Wang, Guihua
Bian, Xueyan
Luo, Qun
Dong, Junwu
Chen, Wenli
Hao, Yan
Wang, Liang
Xu, Guangbiao
Yi, Bin
Liao, Xiaohui
Chen, Chaosheng
Niu, Jianying
Deng, Jin
Chen, Lianhua
Zhang, Yunfang
Zhou, Tianbiao
Li, Guisen
Zhang, Dongliang
Li, Yi
Mao, Huijuan
Lv, Jicheng
Peng, Qingfeng
Zhang, Chenli
Xiang, Peng
Zhang, Junfei
Li, Hang
Xiao, Yan
Liu, Bicheng
-
Funding
Funding for this research was provided by:
AstraZeneca，China
- License Information
-
More Information
Article History
Received: 11 July 2025
Accepted: 16 September 2025
First Online: 28 October 2025
Declarations
:
: This study protocol (28 Nov 2023, Version 2.0) has been approved by the Ethical Review Committee of Affiliated Zhongda Hospital of Southeast University (Approval Number: 2023ZDSYLL313-P01). All participants will provide written informed consent before enrollment. The findings of the study will be published in peer-reviewed journals and will follow the STROBE reporting guideline, [ ] and may be presented at national or international conferences.
: Consents to publish are not required for this manuscript since no patient data are reported.
: The authors declare no competing interests.
